Katica Bajuk Studen
Overview
Explore the profile of Katica Bajuk Studen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jensterle M, Blinc A, Mikhailidis D, Anagnostis P, Schernthaner G, Antignani P, et al.
Curr Vasc Pharmacol
. 2024 Dec;
PMID: 39633519
No abstract available.
2.
Studen K, Domagala B, Gaberscek S, Zaletel K, Hubalewska-Dydejczyk A
Endocrine
. 2024 Aug;
87(1):39-47.
PMID: 39217209
Due to the frequent diagnosis of benign thyroid nodules, it is necessary to deviate from the traditional paradigm based on frequent surgical treatment. This article highlights the evolution of diagnosis...
3.
Sokolowski G, Studen K, Opalinska M, Wegrzyn K, Motyka M, Gilis-Januszewska A, et al.
Intern Emerg Med
. 2024 Jul;
19(7):1921-1928.
PMID: 38967885
The COVID-19 pandemic was a major challenge for all health care employees, but it was also difficult for patients to gain access to health care services. Myxedema coma (MC) is...
4.
Anagnostis P, Mikhailidis D, Blinc A, Jensterle M, Jezovnik M, Schernthaner G, et al.
Curr Vasc Pharmacol
. 2024 Feb;
22(2):153-154.
PMID: 38321894
No abstract available.
5.
Antignani P, Jezovnik M, Blinc A, Mikhailidis D, Anagnostis P, Schernthaner G, et al.
Curr Vasc Pharmacol
. 2024 Jan;
22(2):88-94.
PMID: 38284694
Primary hyperparathyroidism (PHPT) is presented in various forms, including classic PHPT, characterised by increased parathyroid hormone (PTH) secretion, normohormonal PHPT, and normocalcaemic PHPT. Secondary hyperparathyroidism is characterised by increased PTH...
6.
Studen K, Gaberscek S, Zaletel K, Blinc A, Sabovic M, Schernthaner G, et al.
Curr Vasc Pharmacol
. 2023 Nov;
22(1):36-40.
PMID: 37957913
Hypothyroidism and hyperthyroidism, both overt and subclinical, are associated with increased risk of cardiovascular morbidity and mortality. The association between thyroid-stimulating hormone levels and cardiovascular risk has been demonstrated in...
7.
Janez A, Herman R, Poredos P, Mikhailidis D, Blinc A, Sabovic M, et al.
Curr Vasc Pharmacol
. 2023 Oct;
21(6):424-432.
PMID: 37779406
Polycystic ovary syndrome (PCOS) is a highly prevalent endocrine disorder in women of reproductive age. It presents with gynaecologic, metabolic, and psychologic manifestations. The dominant drivers of pathophysiology are hyperandrogenism...
8.
Anagnostis P, Mikhailidis D, Blinc A, Jensterle M, Jezovnik M, Schernthaner G, et al.
Curr Vasc Pharmacol
. 2023 Oct;
21(5):293-296.
PMID: 37779405
Peripheral artery disease (PAD), defined as lower extremity arterial disease, constitutes an underestimated aspect of the menopause-associated risk of atherosclerotic cardiovascular disease (ASCVD). Accumulation of ASCVD risk factors, such as...
9.
Studen K, Gaberscek S, Pirnat E, Bedernjak Bajuk N, Vendramin A, Majcen V, et al.
Endocr Connect
. 2023 Sep;
12(11).
PMID: 37675840
Objective: The optimal corticosteroid treatment regimen for subacute thyroiditis has not yet been established. To avoid side effects, tapering of the initial dose of corticosteroid is recommended. With reducing dose,...
10.
Blinc A, Schernthaner G, Poredos P, Anagnostis P, Jensterle M, Studen K, et al.
Curr Vasc Pharmacol
. 2023 Aug;
21(5):297-303.
PMID: 37559242
Testosterone levels in men begin declining in the early years of adulthood, with a 1-2% reduction/year. Low testosterone levels in men are associated with obesity, metabolic syndrome, diabetes mellitus, dyslipidaemia,...